Gilead slides 4% after coronavirus drug shows limited benefit in moderately ill patients
slipped 4% on Monday after a late-stage coronavirus drug trial showed that remdesivir had limited success treating moderately ill patients.
The company said that remdesivir helped patients in the trial with "moderate" disease recover more quickly when they took it for five days but it had limited benefits for patients who took it for 10 days. Gilead said patients in the group that received remdesivir for five days were 65% more likely to show signs of clinical improvement compared to those who got usual care, without receiving the drug.
Remdesivir has been tested as a treatment for patients with COVID-19. It has been authorized for emergency use by the US Food and Drug Administration and has been approved for use in Japan. While Monday's results affirm that remdesivir does have some success in treating COVID-19 it may raise questions how beneficial it will be overall.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
YouTube at 15: The inside story of YouTube's history - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Lire la suite »
Gilead says new data shows remdesivir coronavirus treatment helped moderately sick patients
Lire la suite »
Russia Approves Flu Drug’s Use Against Covid-19Russia’s Ministry of Health on Saturday approved a flu drug for use in fighting coronavirus after officials said preliminary testing showed hospitalized patients who took the pills recovered more quickly.
Lire la suite »
McConnell and Pelosi's next battle: How to help the 40 million unemployedThe divide over jobless benefits will dominate the fight over a new coronavirus aid package.
Lire la suite »
‘The next patient could be me’: For a family of Filipino doctors, pandemic is personalWhile they toil to save the lives of coronavirus patients, physicians face private struggles, too.
Lire la suite »
Gilead says remdesivir helped moderate COVID-19 patients improveGilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study.
Lire la suite »